United States — National Cancer Institute & United States — National Institutes of Health
12 shared events · Importance 5 · Last updated Aug 21, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Tech
United States — National Cancer Institute: Key funder and coordinator of HCMI, strengthening its leadership in cancer research and precision oncology.
United States — National Institutes of Health: Primary funder of the HCMI project, enhancing its role in cancer research and potentially increasing future funding and prestige.
Aug 05, 2026 · 6 articles
Business
United States — National Cancer Institute: Granted an internal use license to HLA Protein Technologies, facilitating the transfer of TCR-related technology. This aligns with NCI's mission to advance cancer research and may lead to broader adoption of its licensed technologies.
United States — National Institutes of Health: As the parent agency of NCI, the NIH is indirectly involved in the licensing agreement, supporting the advancement of TCR research tools. The license reflects NIH's role in enabling biotech innovation.
Aug 11, 2026 · 6 articles
Tech
United States — National Cancer Institute: Provided funding for the research, supporting its mission to advance cancer research.
United States — National Institutes of Health: Provided funding through its institutes, reinforcing its role in supporting biomedical research.
Aug 20, 2026 · 6 articles
Tech
United States — National Cancer Institute: Provided funding (R01CA237569, R37CA234006) supporting the research.
United States — National Institutes of Health: Parent agency of NCI; provided funding.
Jun 24, 2026 · 7 articles
Tech
United States — National Cancer Institute: Provided funding for the research.
United States — National Institutes of Health: Provided funding for the research.
Jul 15, 2026 · 7 articles
Tech
United States — National Cancer Institute: Provided a cancer center support grant (P30 CA168524). Supports cancer research; no direct financial impact.
United States — National Institutes of Health: Provided grant funding (5-R01-HL 107904-13). Supports its mission of funding biomedical research; no direct financial impact.
Aug 04, 2026 · 6 articles
Tech
United States — National Cancer Institute: Part of NIH that funded the research; aligns with its goals.
United States — National Institutes of Health: Provided funding; supports its mission of medical research.
Jul 20, 2026 · 6 articles
Tech
United States — National Cancer Institute: Provided funding via grant P30CA014089.
United States — National Institutes of Health: Provided funding via grant R25CA225513.
Jul 13, 2026 · 6 articles
Tech
United States — National Cancer Institute: The United States — National Cancer Institute partially funded the study, supporting critical cancer research.
May 19, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States — National Cancer Institute and United States — National Institutes of Health interact across events, view sentiment trends, and discover connected entities.
Open Dashboard